XML 40 R25.htm IDEA: XBRL DOCUMENT v3.24.0.1
STOCK-BASED COMPENSATION PLANS (Tables)
 12 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Shares Under 2019 Omnibus Incentive Plan
Shares GrantedConversion RateTotal Shares Under 2019 Omnibus Plan
Non-Qualified Stock Options4,908,950 1.004,908,950 
Restricted Stock4,231,194 4.0617,178,648 
Performance Shares867,995 4.063,524,059 
Total10,008,139 25,611,657 
Schedule of Weighted-Average Assumptions
The fair value of each option grant was estimated on the date of grant using the Black-Scholes option pricing model with the following weighted-average assumptions for the indicated periods:
202320222021
Dividend yield (1)
1.7 %1.8 %1.8 %
Expected volatility (2)
28.8 %28.8 %27.6 %
Risk-free interest rate (3)
4.0 %3.4 %1.3 %
Expected term of options (in years) (4)
4.24.24.1
Weighted-average grant-date fair value$7.66 $6.42 $6.59 
(1)    Represents the Company's estimated cash dividend yield over the expected term of option grant.
(2) Amount is determined based on analysis of historical price volatility of the Company's common stock. The expected volatility is based on the daily percentage change in the price of the stock over a period equal to the expected term of the option grant.
(3)    Represents the U.S. Treasury yield over the expected term of the option grant.
(4) Represents the period of time that options granted are expected to be outstanding. Based on analysis of historical option exercise activity, the Company has determined that all employee groups exhibit similar exercise and post-vesting termination behavior.
Schedule of Stock Option Activity
A summary of the status of the Company’s stock option plans at December 31, 2023, 2022 and 2021, and changes during the same periods are presented in the tables below.
 2023
 Shares
(000)		Wtd. Avg.
Ex. Price		Wtd. Avg. 
Remaining
Contract Life		Aggregate
Intrinsic 
Value
(000)
Outstanding at Beginning of Year4,872 $28 
Granted768 30 
Exercised(1,023)31 $7,847 
Forfeited(230)29 
Outstanding at End of Year4,387 29 2.9 years$17,491 
Exercisable at End of Year1,942 $29 2.3 years$8,916 

 2022
 Shares
(000)		Wtd. Avg.
Ex. Price		Wtd. Avg. 
Remaining
Contract Life		Aggregate
Intrinsic 
Value
(000)
Outstanding at Beginning of Year4,535 $27 
Granted1,219 27 
Exercised(530)21 $4,065 
Forfeited(352)28 
Outstanding at End of Year4,872 28 3.1 years$8,928 
Exercisable at End of Year1,960 $26 2.4 years$5,864 
 
 2021
 Shares
(000)		Wtd. Avg.
Ex. Price		Wtd. Avg. 
Remaining
Contract Life		Aggregate
Intrinsic 
Value
(000)
Outstanding at Beginning of Year4,533 $23 
Granted1,434 34 
Exercised(1,184)20 $17,289 
Forfeited(248)27 
Outstanding at End of Year4,535 27 3.4 years$35,283 
Exercisable at End of Year1,380 $23 2.5 years$16,433 
Schedule of Non-Vested Stock Option Activity
A summary of the status of the Company’s non-vested employee stock option activity for the years ended December 31, 2023, 2022, and 2021, are presented in the table below: 
 202320222021
 Shares
(000)		Wtd. Avg
Grant
Date
Fair Value		Shares
(000)		Wtd. Avg
Grant
Date
Fair Value		Shares
(000)		Wtd. Avg
Grant
Date
Fair Value
Nonvested Stock Options at Beginning of Year2,913 $6 3,156 $5 3,175 $5 
Granted768 8 1,219 6 1,434 7 
Vested(1,056)6 (1,153)4 (1,212)4 
Forfeited(180)6 (309)6 (241)5 
Nonvested Stock Options at End of Year2,445 $7 2,913 $6 3,156 $5 
Schedule of Restricted Shares
202320222021
Vesting Period(1)
Shares GrantedMarket Price at Grant DateShares GrantedMarket Price at Grant DateShares GrantedMarket Price at Grant Date
1 Year142,314 
28.03 - 32.66
119,849 
23.84 - 29.89
24,634 
32.98 - 34.37
2 Year104,562 
28.03 - 32.66
82,538 
23.84 - 29.17
— 
  -
3 Years302,569 
28.03 - 32.66
261,493 
23.84 - 30.85
606,853 
32.98 - 35.67
4 Years265,719 
28.03 - 32.66
260,149 
23.84 - 29.17
309,955 
32.98 - 35.67
5 Years184,900 
28.03 - 32.66
225,060 
23.84 - 29.17
157,169 
32.98 - 35.67
1,000,064 
$28.03 - 32.66
949,089 
$23.84 - 30.85
1,098,611 
$32.98 - 35.67
(1) Each of these awards cliff vest after the restriction period with no additional restrictions.
Schedule of Restricted Share Award Activity
A summary of restricted share award activity, including award grants, vesting, and forfeitures for the years ended December 31, 2023, 2022, and 2021, are presented in the table below: 
 202320222021
 Shares
(000)		Shares
(000)		Shares
(000)
Nonvested, Beginning of Year3,553 3,760 3,599 
Granted1,027 949 1,099 
Vested(1,058)(935)(759)
Forfeited(144)(221)(179)
Nonvested, End of Year3,378 3,553 3,760 
Schedule of Employee Stock Purchase Plan The following table summarizes shares sold to employees under the 2022 and prior plan in the years ended December 31, 2023, 2022 and 2021:
Plan202320222021Cumulative Shares IssuedWeighted Average Fair Value 2023
2022 Employee Stock Purchase Plan194,241 94,111 — 288,352 $30.29 
Prior Employee Stock Purchase Plan— 126,101 143,892 1,624,122 $—